This study is a randomized clinical trial that wil evaluate the effect of magnesium tab on pregnancy.
Participants will be selected from the population that will be referred to Beheshti and Alzahra Hospital Clinic.Individuals who will fulfill the inclusion criteria will be invited to participate in this study.
Maternal serum magnesium levels of pregnant women with gastational age 12_14 weeks will be measured and those whose serum magnesium levels will be less than1.9 mg per deciliter,will be selected.The participants will be randomly allocated to one of the two groups using a camputer-generated table.
Participants in group A,will be received 200mg effervescent magnesium tab from vittafit company once daily for one month,also they will consume one multimineral tab from alhavi company,that contains 100mg magnesium,once a day till the end of pregnancy.
Participants in group B will be received one multimineral tab daily till the end of pregnancy.
Participants with magnesium serum levels more than 1.9mg per deciliter will be considered as control group C randomly.They will just consume one multimineral tab once a day till the end of pregnancy.
This study will evaluate the outcomes of pregnancy like Intra Uterine Growth Retardation,Preterm labor,Preterm Rapture of membranes,maternal BMI,Neonatal weight,pregnancy induced hypertension,Gestational Diabetes,Cramps of leg,Apgar Score between groups.